Hemostemix Inc HMTXF
Trading Information
- Previous Close Price
- $0.04
- Day Range
- $0.04–0.04
- 52-Week Range
- $0.04–0.07
- Bid/Ask
- $0.03 / $0.10
- Shares Outstanding
- 211.44M
- Market Cap
- $8.09M
- Volume/Avg
- 11,000 / 15,676
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- —
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Dividend Payment Schedule
- —
- Total Yield
- —
Company Profile
Hemostemix Inc is a clinical-stage biotechnology company whose principal business is to develop, manufacture, and commercialize blood-derived stem cell therapies for medical conditions not adequately addressed by current treatments. Its product ACP-01 is derived from a patient's own blood and evaluated in clinical research for ischemic conditions, including Cardiovascular Ischemia, Peripheral Arterial Disease (PAD), Chronic Limb Threatening Ischemia (CLTI), and Vascular Dementia.
- Sector
- Healthcare
- Industry
- Biotechnology
- Stock Style Box
- Small Value
- Total Number of Employees
- —
- Website
- https://www.hemostemix.com
Valuation
|
Metric
|
HMTXF
|
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | — |
Price/Sales | — |
Price/Cash Flow | — |
Price/Earnings
HMTXF
Financial Strength
|
Metric
|
HMTXF
|
|---|---|
Quick Ratio | 0.13 |
Current Ratio | 0.13 |
Interest Coverage | −18.22 |
Quick Ratio
HMTXF
Profitability
|
Metric
|
HMTXF
|
|---|---|
Return on Assets (Normalized) | −734.51% |
Return on Equity (Normalized) | — |
Return on Invested Capital (Normalized) | — |
Return on Assets
HMTXF
Biotechnology Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Vertex Pharmaceuticals Inc
VRTX
| LOCK|RCQ%$> | LOCK|zzlG$ | $133B | |||
| Regeneron Pharmaceuticals Inc
REGN
| LOCK|hvl<Qw | LOCK|#mM?Z | $83B | |||
| Moderna Inc
MRNA
| LOCK|c^cwdp | LOCK|c&& | $80B | |||
| argenx SE ADR
ARGX
| LOCK|m?J$$Yz | LOCK|#pl | $55B | |||
| BeOne Medicines Ltd ADR
ONC
| LOCK|#<D#Dt$ | LOCK|QC | $45B | |||
| Alnylam Pharmaceuticals Inc
ALNY
| LOCK|l&@?Nc< | LOCK|d?@? | $30B | |||
| Royalty Pharma PLC Class A
RPRX
| LOCK|kCw%CsF | LOCK|QJWs | $28B | |||
| Incyte Corp
INCY
| LOCK|l#lv%% | LOCK|K&X | $23B | |||
| BioNTech SE ADR
BNTX
| LOCK|j<Mw!D | LOCK|c%k | $22B | |||
| Jazz Pharmaceuticals PLC
JAZZ
| LOCK|!yFQKZ | LOCK|@# | $14B |
United States